Pfizer launches Elranatamab in India for relapsed or refractory multiple myeloma
BCMA-directed bispecific antibody is available as a fixed-dose subcutaneous injection for adult patients who have received four…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pfizer India
Industry calls Union Budget 2026 a defining moment for India’s biopharma future
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…
Pfizer India, State of Goa launch ‘Project Parivartan’ to tackle AMR
The project will be implemented from November 2024 to April 2028, initially at GMC and two district hospitals, with plans to…
Pfizer appoints Meenakshi Nevatia as MD and Additional Director from April, 2023
Nevatia has 30 years of business leadership and consulting experience with companies such as McKinsey, Novartis and Stryker…
Pfizer announces 12-week paternity leave policy for its employees
The policy will be applicable for biological and adoptive fathers from 1st January, 2023, onwards
Pfizer India partners with Father Muller Research to strengthen evidence generation and encourage…
Researchers will access existing Electronic Health Record (EHR) to develop a deeper understanding on drug efficacy in proven…
Pfizer India partners with Max Super Speciality Hospitals
The aim of the partnership is to enhance scope of care and create avenues for new research
Indian Consulate holds virtual meet to attract foreign investors for PLI scheme, bulk drugs and…
Government officials from Himachal Pradesh, Gujarat and Andhra Pradesh showcase opportunities and incentives for investors
OPPI organises conference on future of supply chain management in Mumbai
Key stakeholders of the pharma industry congregated at the event to confer and converse on the blueprint to build an effective and…